SVB Leerink analyst Thomas Smith maintains 89bio (NASDAQ:ETNB) with a Outperform and lowers the price target from $50 to $29.
Invitae Q3 Adj. EPS $(0.81) Misses $(0.71) Estimate, Sales $114.39M Miss $126.55M Estimate
Invitae (NYSE:NVTA) reported quarterly losses of $(0.81) per share which missed the analyst consensus estimate of $(0.71) by 14.08 percent. This is a 30.65 percent decrease over losses of $(0.62) per share from the same
